The role of phenotype on ventilation and exercise capacity in patients affected by COPD: a retrospective study
Keywords:
COPD, cardiopulmonary exercise test, ventilation, exercise capacity, phenotype, emphysemaAbstract
Background: The idea of phenotype in chronic obstructive pulmonary disease (COPD) has evolved in the last decades, and the importance of peculiar treatment strategies has now been acknowledged. Although dyspnea and exercise limitation are hallmarks of COPD, this aspect has never been fully explored in literature in terms of disease phenotype. The aim of the present study was to explore the relevance of clinical COPD phenotypes on exercise ventilation and maximal capacity.
Methods: In this observational cohort retrospective study we analyzed the data of 50 COPD patients who underwent cardiopulmonary exercise test, categorized as emphysematous (n=29), and non-emphysematous (n=21) according to a previously validated model.
Results: We found a significant difference in terms of VE/VCO2 slope (median values 32.4 vs 28.0, p=0.015) and VE/VCO2 ratio at nadir (median values 37 vs 33, p=0.004), which resulted higher in emphysematous patients, who also presented lower PETCO2 values (median values 32.6 vs 35.6, p=0.008). In a subgroup of 31 tests which met the maximality criteria, emphysematous patients presented a significantly lower work rate at peak (median value 51 vs 72 % predicted, p=0.016), and showed a lower peak oxygen consumption, although at the limit of significance (median values of 63 vs 85 % predicted, p=0.051).
Conclusions: This study extends our knowledge about the characterization of the COPD phenotypical expression of disease, showing that patients affected by emphysema are more prone to ventilatory inefficiency during exercise, and that this is likely to be an important cause of their overall reduced exercise capacity.
References
Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS. The emphysematous and bronchial types of chronic airways obstruction. Lancet 1966;287:830–5.
Agustí A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med 2019;381:1248-56.
Han MLK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: The future of COPD. Am J Respir Crit Care Med 2010;182:598-604.
Lange P, Halpin DM, O’Donnell DE, Macnee W. Diagnosis, assessment, and phenotyping of COPD: beyond FEV1. Int J Chron Obstruct Pulmon Dis 2016;11 Spec Iss:3-12. doi: 10.2147/COPD.S85976.
Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, et al. A review of national guidelines for management of COPD in Europe. Eur Respir J 2016;47:625–37.
Di Marco F, Terraneo S, Job S, Rinaldo RF, Sferrazza Papa GF, Roggi MA, et al. Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry. Respir Med 2017;127:7-13.
Chen L-F, Wang CH, Chou PC, Ho S, Joa W-C, Sheng T-F, et al. Association between emphysema score, six-minute walk and cardiopulmonary exercise tests in COPD. Open Respir Med J 2012;6:104-10.
Paoletti P, De Filippis F, Fraioli F, Cinquanta A, Valli G, Laveneziana P, et al. Cardiopulmonary exercise testing (CPET) in pulmonary emphysema. Respir Physiol Neurobiol 2011;179:167-73.
Crisafulli E, Alfieri V, Silva M, Aiello M, Tzani P, Milanese G, et al. Relationships between emphysema and airways metrics at high-resolution computed tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients. Respir Med 2016;117:207-14.
Teopompi E, Tzani P, Aiello M, Gioia MR, Marangio E, Chetta A. Excess ventilation and ventilatory constraints during exercise in patients with chronic obstructive pulmonary disease. Respir Physiol Neurobiol 2014;197:9–14.
Márquez-Martín E, Ramos PC, López-Campos JL, Gotarredona M del PS, Herrero SN, Aguilar RT, et al. Components of physical capacity in patients with chronic obstructive pulmonary disease: Relationship with phenotypic expression. Int J Chron Obstruct Pulmon Dis 2011;6:105-12.
American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-77. Erratum in: Am J Respir Crit Care Med 2003;1451-2. Comment in: ATS/ACCP statement on cardiopulmonary exercise testing. [Am J Respir Crit Care Med 2003]
Neder JA, Berton DC, Arbex FF, Alencar MC, Rocha A, Sperandio PA, et al. Physiological and clinical relevance of exercise ventilatory efficiency in COPD. Eur Respir J 2017;49:1-13.
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948–68.
Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J 2019;53. pii: 1900164.
Sun XG, Hansen JE, Garatachea N, Storer TW, Wasserman K. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med 2002;166:1443-8.
MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CPM, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-35.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22.
Camiciottoli G, Bigazzi F, Paoletti M, Cestelli L, Lavorini F, Pistolesi M. Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD. Eur Respir J. 2013;42(3):626–35.
Jones JH, Zelt JT, Hirai DM, Diniz C V., Zaza A, O’Donnell DE, et al. Emphysema on thoracic CT and exercise ventilatory inefficiency in mild-to-moderate COPD. COPD 2017;14:210–8.
Neder JA, Arbex FF, Alencar MCN, O’donnell CDJ, Cory J, Webb KA, et al. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur Respir J 2015;45:377-87.
Malhotra R, Bakken K, D’Elia E, Lewis GD. Cardiopulmonary exercise testing in heart failure. JACC Hear Fail 2016;4:607-16.
Apostolo A, Laveneziana P, Palange P, Agalbato C, Molle R, Popovic D, et al. Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 2015;189:134-40. A
Zhai Z, Murphy K, Tighe H, Wang C, Wilkins MR, Gibbs JSR, et al. Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest 2011;140:1284-91.
McCabe C, Deboeck G, Harvey I, Ross RM, Gopalan D, Screaton N, et al. Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism. Thromb Res 2013;132:659-65.
Calverley P. Understanding breathlessness in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:564–5.
Poon CS, Tin C, Song G. Submissive hypercapnia: Why COPD patients are more prone to CO2 retention than heart failure patients. Respir Physiol Neurobiol 2015;216:86-93.
Dubé BP, Guerder A, Morelot-Panzini C, Laveneziana P. The clinical relevance of the emphysema-hyperinflated phenotype in COPD. COPD Res Pract 2016;2:1-11.
Lahaije AJMC, Van Helvoort HAC, Dekhuijzen PNR, Vercoulen JH, Heijdra YF. Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1. Respir Med 2013;107:834-40.
Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, López-Collazo E, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506-12.
Guenette JA, Webb KA, O’Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J 2012;40:322-9.
Bussotti M, Magrì D, Previtali E, Farina S, Torri A, Matturri M, et al. End-tidal pressure of CO2 and exercise performance in healthy subjects. Eur J Appl Physiol 2008;103:727-32.
Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder JA, et al. Use of exercise testing in the evaluation of interventional efficacy: An official ERS statement. Eur Respir J 2016;47:429-60.
Published
Issue
Section
License
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
